DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT- THE GOOD, THE BAD, AND THE FUTURE

Author(s)

Machado M1, Fonseca E2, Fonseca M31GlaxoSmithKline Brazil, Rio de Janeiro, Brazil, 2Federal University of São Paulo, São Paulo, Brazil, 3Axia.Bio, São Paulo, Brazil

OBJECTIVES: Despite the premise of universal access supported by its Constitution, the Brazilian healthcare system is subject to similar financing issues as in other jurisdictions worldwide.  A misunderstanding between Constitutional rights and healthcare budget restrictions leads to the controversial model of procedural justice.  The objective was to describe the characteristics of the current decision-making scenario in Brazil using Health Technology Assessment (HTA), its main actors, consequences and future opportunities. METHODS: A review of HTA regulation in Brazil and the published literature on the topic was conducted.  The Brazilian HTA model was discussed and strengths and weaknesses highlighted. RESULTS: Over the years, drug expenditures and healthcare demand have grown exponentially in Brazil.  In 2006, the Brazilian Ministry of Health (MoH) created a HTA process (Regulation #152).  The main objective was to align the dynamics of health technology decisions with population social needs, epidemiological profile, and healthcare system financing characteristics.  The principal components are a clinical review and economic analysis of technologies under evaluation.  Multiple government players are involved, but no reference to external involvement.  Health technology decisions take into consideration: a) the relevance/impact of the technology within the system, and b) the safety, effectiveness, and cost-effectiveness of the appraised technologies.  No reference was found to what is considered cost-effective/efficient for the system.  Proposed HTA regulation changes are underway and include: rapid response, societal engagement (i.e., public consultation of MoH decisions), and changes in decision determinants (i.e., economic impact to be least important). CONCLUSIONS: Currently, Brazil holds an informed health technology decision-making process.  However, clear/objective parameters for aiding decisions have not been described or yet proposed.  Uncertainty still remains with regards to efficient health technology decisions.  Current initiatives to improve HTA process are controversial.  In the future, HTA could serve as a mediator between constitutional obligations and current budgetary restrictions in the country.

Conference/Value in Health Info

2011-05, ISPOR 2011, Baltimore, MD, USA

Value in Health, Vol. 14, No. 3 (May 2011)

Code

PHP35

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Formulary Development

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×